Table 1.
Established theranostic agents in current use in the clinic
| Clinical indication | Diagnostic agent | Therapeutic agent |
| Hyperthyroidism or thyroid cancer | 123I-iodide | 131I-iodide |
| Adrenergic tumours | 123I-iobenguane | 131I-iobenguane |
| Bone metastases from prostate cancer | 99mTc-MDP | 223Ra chloride |
| Non-Hodgkins lymphoma | 111In-ibritumomab | 90Y-ibritumomab |
| Neuroendocrine tumours | 68Ga-DOTATATE | 177Lu-DOTATATE |
| Prostate cancer | 68Ga-DKFZ-PSMA-11 | 177Lu-DKFZ-PSMA-617 |